Therapeutic effects of Echinococcus granulosus cystic fluid on allergic airway inflammation.
Airway Resistance
/ drug effects
Animals
Bronchoalveolar Lavage Fluid
/ cytology
CD4-Positive T-Lymphocytes
/ drug effects
Cyst Fluid
/ chemistry
Cytokines
/ metabolism
Disease Models, Animal
Echinococcus granulosus
/ chemistry
Eosinophils
/ drug effects
Female
Host-Parasite Interactions
/ immunology
Hypersensitivity
/ drug therapy
Inflammation
/ drug therapy
Interleukin-4
/ immunology
Lymph Nodes
/ immunology
Mice
Mice, Inbred C57BL
Sheep
Specific Pathogen-Free Organisms
Spleen
/ immunology
T-Lymphocytes, Regulatory
/ drug effects
Th2 Cells
/ immunology
Allergic airway inflammation
Cystic fluid
Echinococcus granulosus
Treg cell
Journal
Experimental parasitology
ISSN: 1090-2449
Titre abrégé: Exp Parasitol
Pays: United States
ID NLM: 0370713
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
01
11
2018
revised:
04
01
2019
accepted:
10
02
2019
pubmed:
15
2
2019
medline:
28
3
2019
entrez:
15
2
2019
Statut:
ppublish
Résumé
Previous studies showed that Echinococcus granulosus infection reduces allergic airway inflammation in experimentally infected hosts and the cystic fluid of E. granulosus is known to activate regulatory T (CD4
Identifiants
pubmed: 30763570
pii: S0014-4894(18)30491-0
doi: 10.1016/j.exppara.2019.02.003
pii:
doi:
Substances chimiques
Cytokines
0
Interleukin-4
207137-56-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
63-70Informations de copyright
Copyright © 2019. Published by Elsevier Inc.